Trial Profile
The PUMP Trial - Comparison of diagnostic accuracy of PSMA PET/MRI, USS MRI Fusion Biopsy and "Prolaris" genomic risk stratifier in reclassification of men on Active Surveillance with low risk prostate cancer
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Apr 2022
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- Acronyms PUMP
- 15 Sep 2017 New trial record